Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000919574-98-000618
Filing Date
1998-06-17
Accepted
1998-06-17 00:00:00
Documents
1
SROs
AMEX

Document Format Files

Seq Description Document Type Size
1 SC 13G 8475
  Complete submission text file 0000919574-98-000618.txt   12252
Mailing Address CURRAN PARTNERS LP 230 PARK AVENUE NEW YORK NY 10169
Business Address CURRAN PARTNERS LP 230 PARK AVENUE NEW YORK NY 10169 2128082400
CURRAN JOHN P (Filed by) CIK: 0000026256 (see all company filings)

 

Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 225 EAST DEERPATH STE 250 LAKE FOREST IL 60045 7082958678
NEOPHARM INC (Subject) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-49245 | Film No.: 98649795
SIC: 8731 Services-Commercial Physical & Biological Research